Furthermore, dihydropyridine Ca2+ channel blockers, which are known to block the selective increase in MAO-A in the senescence-accelerated mouse model [32], may improve learning and performance in animals [60] and may improve age-associated and AD-related memory impairment in humans [61,62]. The gene discussed is MAOA; the disease is memory impairment.